Key Insights

Highlights

Success Rate

73% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 54/100

Termination Rate

23.5%

4 terminated out of 17 trials

Success Rate

73.3%

-13.2% vs benchmark

Late-Stage Pipeline

41%

7 trials in Phase 3/4

Results Transparency

55%

6 of 11 completed with results

Key Signals

6 with results73% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (3)
P 1 (2)
P 2 (1)
P 3 (4)
P 4 (3)

Trial Status

Completed11
Terminated4
Enrolling By Invitation1
Unknown1

Trial Success Rate

73.3%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT06000566CompletedPrimary

Drug Compliance and Affecting Factors in Juvenile Idiopathic Arthritis

NCT02377245Enrolling By InvitationPrimary

Juvenile Inflammatory Rheumatism (JIR) Cohorte

NCT00807846Phase 4CompletedPrimary

A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects

NCT00688545TerminatedPrimary

Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis

NCT02067962Not ApplicableCompletedPrimary

Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing

NCT01412021CompletedPrimary

Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis

NCT00511329Phase 2TerminatedPrimary

Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease

NCT00868751Not ApplicableTerminatedPrimary

Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis

NCT00637780Phase 4TerminatedPrimary

Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis

NCT00731965Phase 4CompletedPrimary

Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis

NCT02001844Not ApplicableCompletedPrimary

Foot Orthoses (FOs) on Pain, Quality of Life and the Gait With Children Diagnosed With JIA

NCT00034853Phase 3CompletedPrimary

Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)

NCT00279747Phase 3CompletedPrimary

A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)

NCT00426218Phase 1CompletedPrimary

Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

NCT00652925Phase 3CompletedPrimary

A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA

NCT00001614Phase 1CompletedPrimary

The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis

NCT00012506Phase 3Unknown

The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis

Showing all 17 trials

Research Network

Activity Timeline